Globe Life Inc. Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Net Income: $266 million ($3.29 per share), up from $255 million ($3.01 per share) year-over-year.

Net Operating Income: $274 million ($3.39 per share), an 8% increase from $3.14 per share a year ago.

Full Year 2025 Net Operating Income: $14.52 per share, slightly above previous guidance.

Return on Equity: 20.9% (GAAP), with book value per share at $74.17 (excluding AOCI).

Premium Revenue: Total premium revenue grew 5% in Q4; life premium revenue increased 3% to $850 million; health premium revenue rose 9% to $392 million.

Administrative Expenses: $92 million for the quarter, up 1% year-over-year, maintaining 7.4% of premium.

2Strategic Updates and Business Highlights

Globe Life focuses on providing financial security to the underserved lower middle to middle-income market, highlighting a significant growth opportunity due to high underinsurance rates.

The company is investing in technology to improve agent productivity and customer conversion rates, particularly in the direct-to-consumer channel, which saw a 24% increase in net life sales.

The agent count has nearly doubled over the past decade, with ongoing recruitment strategies targeting individuals from diverse backgrounds rather than just experienced insurance agents.

The establishment of Globe Life Re LTD in Bermuda aims to reinsure a portion of new and in-force policies, with initial transactions involving $1.2 billion in statutory reserves.

3Forward Guidance and Outlook

2026 Guidance:

Expected net operating earnings per diluted share: $14.95 to $15.65 (5% growth at midpoint).

Total premium revenue growth anticipated at 7% to 8%.

Life premium revenue growth projected at 4% to 4.5%; health premium revenue expected to grow 14% to 16%.

Anticipated underwriting margins: Life segment at 41.5% to 44.5%; Health segment at 23% to 27%.

Expected excess cash flow for 2026: $625 million to $675 million.

4Bad News, Challenges, or Points of Concern

Agent Turnover: Higher than expected turnover in the agent count, particularly affecting American Income Life, which saw a 2% decline in average producing agents despite a 10% increase in net life sales.

Claims Trends: Seasonally high claims in the fourth quarter for both individual and group health products, with some unexpected severity in group lines.

Market Dynamics: Potential pressures from the Medicare Advantage market could impact future sales of Medicare Supplement products, although the company remains focused on maintaining pricing for profitability rather than chasing market share.

Investment Income: Excess investment income decreased by $8 million year-over-year, attributed to lower average yields and growth in average policy liabilities.

5Notable Q&A Insights

Lapse Rates: First-year lapses were higher than anticipated in direct-to-consumer and Liberty National channels, attributed to fluctuations in agent productivity and sales channels.

Medicare Supplement Dynamics: The company expects stable claims trends and adequate rate increases to restore margins to normal levels in 2026, despite potential volatility in health remeasurement gains.

Agent Retention Initiatives: New initiatives are being implemented to improve agent retention, particularly in response to recent turnover trends.

Investment Portfolio: Minimal exposure to software companies and AI-related risks, with a conservative investment strategy focusing on long-term stability. Overall, Globe Life Inc. reported solid financial results and maintained a positive outlook for 2026, despite facing challenges in agent retention and claims trends. The strategic focus on underserved markets and technology investments positions the company for continued growth.